人工智能在儿童康复结局评估中的应用:范围综述
该范围综述检索MEDLINE、CINAHL、Embase和IEEE Xplore至2025年6月9日,纳入51项研究,考察AI在儿童康复结局评估中的应用。研究多为探索性、临床前或早期试点阶段,脑瘫儿童尤其是步态分析研究最多,运动相关结局为主,非运动领域稀少。监督机器学习最常用,方法异质性大、外部验证有限和样本量小限制临床转化。
要点
- AI在儿童康复结局评估中多用于步态等运动相关任务,脑瘫儿童研究最多。
- 监督机器学习最常用,模型选择与数据模态和任务需求密切相关。
- 方法异质性大、外部验证有限和样本量小限制可比性与临床转化。
核心结论
- AI在儿童康复结局评估中处于新兴快速发展阶段,运动相关应用证据最强,尤其步态分析。
- 现有AI工具多起支持与分析作用,尚未整合到实时临床决策中。
研究设计与样本
- 遵循PRISMA-ScR指南的范围综述,检索MEDLINE、CINAHL、Embase和IEEE Xplore自建库至2025年6月9日,共11,370条记录。
- 51项研究符合纳入标准,采用PCC框架筛选,Covidence由三名评审员提取数据。
主要发现
- 多数研究为探索性,处于临床前或早期试点阶段。
- 脑瘫儿童是最常研究人群,尤其涉及步态分析。
- AI应用主要聚焦运动相关结局,包括步态、运动质量、上肢功能和步行能力,认知或行为等非运动领域稀少。
- 监督机器学习最常用,其次是神经网络和深度学习方法。
- AI最常用于分类、预测和自动量化或评分。
关键数值与推荐
- 报告AI模型性能时提取每项研究提供的最高指标(≥90%准确率、F1分数、灵敏度或特异度)。
临床怎么用
- 当前AI工具可辅助儿童康复结局的自动化、标准化评估,但应视为支持性分析工具。
- 临床采纳需关注方法学严谨性、外部验证和更广泛人群与结局领域的代表性。
局限性
- 方法学异质性大、外部验证有限和样本量小,限制可比性和临床转化。
- 研究多为探索性、临床前或早期试点阶段,非运动领域证据稀少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Artificial intelligence (AI) is increasingly being applied in healthcare, with growing potential to enhance rehabilitation. In pediatric rehabilitation, traditional outcome measures are resource-intensive, time-consuming, and prone to variability, limiting their scalability. AI offers opportunities to automate, standardize, and expand access to outcome assessment. However, the scope, methodological rigor, and clinical utility of AI applications in this field remain unclear. This scoping review examined how AI has been applied to pediatric rehabilitation outcome assessment, focusing on populations studied, AI methods and models applied, outcome domains, stage of implementation, and reported limitations. METHODS: A scoping review was conducted in accordance with PRISMA-ScR guidelines MEDLINE (Ovid), CINAHL (EBSCOhost), Embase (Ovid), and IEEE Xplore were searched from database inception to June 9, 2025, yielding 11,370 records; 51 studies met the eligibility criteria and were included. Study selection followed the Population, Concept, and Context (PCC) framework. Screening and data extraction were performed in Covidence by three reviewers with piloting at each stage. Data were synthesized descriptively in tables and narrative summaries. Reported AI model performance was extracted as the highest metric provided in each study (≥ 90% accuracy, F1-score, sensitivity, or specificity). RESULTS: Fifty-one studies met the inclusion criteria. Most studies were exploratory and conducted at preclinical or early pilot stages. Children with cerebral palsy were the most frequently studied population, particularly in relation to gait analysis. AI applications were predominantly focused on motor-related outcomes, including gait, movement quality, upper-limb function, and ambulation ability, while non-motor domains such as cognitive or behavioral outcomes were sparsely represented. Supervised machine learning was the most commonly used AI type, followed by neural networks and deep learning approaches, with model selection closely aligned to data modality and task requirements. AI was most often applied for classification, prediction, and automated quantification or scoring. While several studies reported high performance for specific tasks, methodological heterogeneity, limited external validation, and small sample sizes constrained comparability and clinical translation. CONCLUSION: AI-based outcome assessment in pediatric rehabilitation is an emerging and rapidly evolving field, with the strongest evidence to date in motor-related applications, particularly gait analysis. Current AI tools remain largely supportive and analytical, rather than integrated into real-time clinical decision-making. Future research should prioritize methodological rigor, broader representation of pediatric populations and outcome domains, feasibility and implementation studies, and explicit consideration of ethical and equity-related issues to support responsible and clinically meaningful adoption of AI in pediatric rehabilitation.
引用
- Naghdi N, Farhat A, Amara M, et al. Use of artificial intelligence for outcome assessment in pediatric rehabilitation: a scoping review. J Neuroeng Rehabil. 2026. PMID: 41787455. doi:10.1186/s12984-026-01927-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。